DR. LUIS ALVAREZ NIDEA MD
Prescription History 1154311751
Internal Medicine - Gastroenterology in South Bend, IN

NPI Status: Active since October 25, 2005

Contact Information

621 MEMORIAL DR STE 511
SOUTH BEND, IN
ZIP 46601
Phone: (574) 544-5580
Fax: (574) 544-5579

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. LUIS ALVAREZ NIDEA MD, an active Gastroenterology specialist practicing in South Bend, IN. Our medical registry currently tracks 14 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 629 documented patient claims. Among these therapy options, the most frequently utilized medication is Pantoprazole Sodium, which accounts for 141 claims alone.


Dicyclomine Hcl

Generic Formulation: Dicyclomine HclSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 27
30-Day Fills 27.0
Days Supply 310
IN State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills44.3
Peer Average Days Supply1,206
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $265.03 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.82

State Avg Cost Per Claim

$30.18

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Diphenoxylate-Atropine

Generic Formulation: Diphenoxylate Hcl/AtropineSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 19
30-Day Fills 19.0
Days Supply 159
IN State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills23.1
Peer Average Days Supply469
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $331.04 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.42

State Avg Cost Per Claim

$40.15

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat diarrhea. It helps to decrease the number and frequency of bowel movements. It works by slowing the movement of the intestines. Diphenoxylate is similar to opioid pain relievers, but it acts mainly to slow the gut. Atropine belongs to a class of drugs known as anticholinergics, which help to dry up body fluids and also slow gut movement. This medication should not be used to treat diarrhea caused by certain types of infection (such as C. difficile-associated diarrhea following antibiotic therapy). Talk to your doctor for more details. This medication is not recommended for use in children younger than 6 years due to an increased risk of serious side effects (such as breathing problems).

Famotidine

Generic Formulation: FamotidineSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 39
30-Day Fills 96.3
Days Supply 2,890
IN State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills25.5
Peer Average Days Supply263
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 56.0% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $772.34 across this reporting matrix range.

Provider Avg Cost Per Claim

$19.80

State Avg Cost Per Claim

$19.65

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.

Therapeutic Applications

Famotidine is used to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed. This medication is also used to treat certain stomach and throat (esophagus) problems (such as erosive esophagitis, gastroesophageal reflux disease-GERD, Zollinger-Ellison syndrome). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as cough that doesn't go away, stomach pain, heartburn, and difficulty swallowing. Famotidine belongs to a class of drugs known as H2 blockers. This medication is also available without a prescription. It is used to prevent and treat heartburn and other symptoms caused by too much acid in the stomach (acid indigestion). If you are taking this medication for self-treatment, it is important to read the manufacturer's package instructions carefully so you know when to consult your doctor or pharmacist.

Gavilyte-C

Generic Formulation: Peg3350/Sod Sulf,bicarb,cl/KclSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 18
30-Day Fills 18.0
Days Supply 20
IN State Average Benchmarks
Peer Average Claims60.0
Peer Average 30-Day Fills60.7
Peer Average Days Supply88
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 70.0% less volume than the regional standard for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $272.71 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.15

State Avg Cost Per Claim

$16.80

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

PEG (polyethylene glycol) with electrolyte is used to clean out the intestines before certain bowel exam procedures such as colonoscopy or barium enema X-rays. It is a laxative that works by drawing large amounts of water into the colon. This effect results in watery bowel movements. Clearing stool from the intestines helps your doctor to better examine the intestines during your procedure.

Gavilyte-G

Generic Formulation: Peg3350/Sod Sulf,bicarb,cl/KclSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 36
30-Day Fills 36.0
Days Supply 96
IN State Average Benchmarks
Peer Average Claims52.0
Peer Average 30-Day Fills54.4
Peer Average Days Supply130
Conservative Utilization

This provider writes prescriptions for this formulation 30.8% less frequently than the standard regional baseline metric for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $569.83 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.83

State Avg Cost Per Claim

$14.33

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

PEG (polyethylene glycol) with electrolyte is used to clean out the intestines before certain bowel exam procedures such as colonoscopy or barium enema X-rays. It is a laxative that works by drawing large amounts of water into the colon. This effect results in watery bowel movements. Clearing stool from the intestines helps your doctor to better examine the intestines during your procedure.

Humira Pen

Generic Formulation: AdalimumabSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 336
IN State Average Benchmarks
Peer Average Claims16.0
Peer Average 30-Day Fills17.4
Peer Average Days Supply483
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $90,738.00 across this reporting matrix range.

Provider Avg Cost Per Claim

$7,561.50

State Avg Cost Per Claim

$8,326.09

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS.

Therapeutic Applications

Adalimumab is used to reduce pain and swelling due to certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, ankylosing spondylitis). This medication is also used to treat certain skin disorders (such as plaque-type psoriasis, hidradenitis suppurativa). It works by blocking a protein (tumor necrosis factor or TNF) found in the body's immune system that causes joint swelling and damage in arthritis as well as red scaly patches in psoriasis. Adalimumab belongs to a class of drugs known as TNF blockers. By reducing joint swelling, this medication helps to reduce further joint damage and preserve joint function. Adalimumab is also used to treat certain bowel conditions (Crohn's disease, ulcerative colitis) and a certain eye disease (uveitis).

Humira(Cf) Pen

Generic Formulation: AdalimumabSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 364
IN State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills35.3
Peer Average Days Supply993
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 60.6% less volume than the regional standard for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $96,393.96 across this reporting matrix range.

Provider Avg Cost Per Claim

$7,414.92

State Avg Cost Per Claim

$8,782.24

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS.

Therapeutic Applications

Adalimumab is used to reduce pain and swelling due to certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, ankylosing spondylitis). This medication is also used to treat certain skin disorders (such as plaque-type psoriasis, hidradenitis suppurativa). It works by blocking a protein (tumor necrosis factor or TNF) found in the body's immune system that causes joint swelling and damage in arthritis as well as red scaly patches in psoriasis. Adalimumab belongs to a class of drugs known as TNF blockers. By reducing joint swelling, this medication helps to reduce further joint damage and preserve joint function. Adalimumab is also used to treat certain bowel conditions (Crohn's disease, ulcerative colitis) and a certain eye disease (uveitis).

Linzess

Generic Formulation: LinaclotideSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 24
30-Day Fills 30.0
Days Supply 880
IN State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills40.3
Peer Average Days Supply1,203
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $16,271.12 across this reporting matrix range.

Provider Avg Cost Per Claim

$677.96

State Avg Cost Per Claim

$771.63

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

See also Warning section. Linaclotide is used to treat certain types of bowel problems (irritable bowel syndrome with constipation, chronic idiopathic constipation). It works by increasing fluid in your intestines and helping speed up movement of food through the gut. Linaclotide may improve stool texture and lessen symptoms such as bloating, abdominal pain/discomfort, straining, and feelings of incomplete bowel movements.

Lubiprostone

Generic Formulation: LubiprostoneSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 40
30-Day Fills 40.0
Days Supply 1,135
IN State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills25.2
Peer Average Days Supply615
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 90.5% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $9,632.69 across this reporting matrix range.

Provider Avg Cost Per Claim

$240.82

State Avg Cost Per Claim

$293.64

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Member of a bicyclic fatty acid class of compounds derived from PROSTAGLANDIN E1 involved in chloride channel gating.

Therapeutic Applications

This medication is used to treat certain types of constipation (chronic idiopathic constipation, irritable bowel syndrome with constipation). Chronic idiopathic constipation has an unknown cause and is not due to diet, other diseases, or drugs. Lubiprostone is also used to treat constipation caused by opioid medications in people with ongoing pain due to medical conditions other than cancer. This medication may improve symptoms such as bloating and abdominal discomfort, improve stool texture, lessen the need to strain, and decrease the feeling of not completely relieving oneself. Lubiprostone belongs to a class of drugs known as chloride channel activators. It works by increasing the amount of fluid within your intestines, making the passage of stool easier.

Metoclopramide Hcl

Generic Formulation: Metoclopramide HclSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 21
30-Day Fills 27.0
Days Supply 549
IN State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills31.1
Peer Average Days Supply806
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $121.02 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.76

State Avg Cost Per Claim

$10.32

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A dopamine D2 antagonist that is used as an antiemetic.

Therapeutic Applications

Metoclopramide is used by diabetic patients who have poor emptying of their stomachs (gastroparesis). Treating gastroparesis can decrease symptoms of nausea, vomiting, and stomach/abdominal fullness. Metoclopramide works by blocking a natural substance (dopamine). It speeds up stomach emptying and movement of the upper intestines. This drug is not recommended for use in children due to an increased risk of serious side effects (such as muscle spasms/uncontrolled muscle movements). Ask the doctor or pharmacist for details.

Omeprazole

Generic Formulation: OmeprazoleSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 23
30-Day Fills 58.0
Days Supply 1,740
IN State Average Benchmarks
Peer Average Claims109.0
Peer Average 30-Day Fills243.5
Peer Average Days Supply7,132
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 78.9% less volume than the regional standard for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $538.74 across this reporting matrix range.

Provider Avg Cost Per Claim

$23.42

State Avg Cost Per Claim

$14.59

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

Therapeutic Applications

Omeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Omeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). If you are self-treating with this medication, over-the-counter omeprazole products are used to treat frequent heartburn (occurring 2 or more days a week). Since it may take 1 to 4 days to have full effect, these products do not relieve heartburn right away. For over-the-counter products, carefully read the package instructions to make sure the product is right for you. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar brand names may contain different ingredients meant for different purposes. Taking the wrong product could harm you.

Pantoprazole Sodium

Generic Formulation: Pantoprazole SodiumSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 141
30-Day Fills 291.0
Days Supply 8,699
IN State Average Benchmarks
Peer Average Claims86.0
Peer Average 30-Day Fills180.3
Peer Average Days Supply5,212
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 64.0% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,845.92 across this reporting matrix range.

Provider Avg Cost Per Claim

$13.09

State Avg Cost Per Claim

$15.93

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.

Therapeutic Applications

Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

Peg 3350-Electrolyte

Generic Formulation: Sodium Chloride/Nahco3/Kcl/PegSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 135
30-Day Fills 135.0
Days Supply 186
IN State Average Benchmarks
Peer Average Claims75.0
Peer Average 30-Day Fills76.7
Peer Average Days Supply162
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 80.0% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,151.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$23.35

State Avg Cost Per Claim

$20.68

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

PEG (polyethylene glycol) with electrolyte is used to clean out the intestines before certain bowel exam procedures such as colonoscopy or barium enema X-rays. It is a laxative that works by drawing large amounts of water into the colon. This effect results in watery bowel movements. Clearing stool from the intestines helps your doctor to better examine the intestines during your procedure.

Sod Sulf-Potass Sulf-Mag Sulf

Generic Formulation: Sodium, Potassium,mag SulfatesSpecialty: Gastroenterology
Provider Metrics Summary
Total Claims 81
30-Day Fills 81.0
Days Supply 99
IN State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills23.7
Peer Average Days Supply78
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 268.2% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,085.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$75.14

State Avg Cost Per Claim

$81.53

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Sodium/potassium/magnesium sulfate solution is used to clean out the intestines before a certain bowel exam procedure (colonoscopy). It is a laxative that works by drawing large amounts of water into the colon. This causes watery bowel movements. Clearing stool from the intestines helps your doctor to better examine the intestines during your procedure.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. LUIS ALVAREZ NIDEA MD provides transparency into local medical care patterns within South Bend, IN.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Gastroenterology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.